Safety data from a phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin bound paclitaxel (nab paclitaxel) and carboplatin in HER2+ locally advanced breast cancer
D. Yardlev, E. Raefsky, R. Castillo, A. Lahiry, D. Thompson, S. Hanson, C. Meng, D. Knauer, V. Trieu, N. DesaiVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70549-4
File:
PDF, 61 KB
english, 2008